GenMark Diagnostics (GNMK) Tops Q3 EPS by 4c

GenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.36 million.

GUIDANCE:

GenMark Diagnostics sees FY2016 revenue of $47-51 million, versus the consensus of $49.0 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c